The best banks for healthtech startups in 2026

The best banks for healthtech startups compared

Bank total assets come from FDIC BankFind call reports (03/31/2026); fees and coverage were verified 08/02/2026; yields carry their own as-of date in each cell.

*2% Cashback applies on the Rho Card with Daily Terms for Rho Platinum members, on your first $1 million in eligible spend per year — the standard limit (spending more than $1M a year? Talk to sales). Standard Daily Terms rate: 1.5%. Monthly Terms: 1.75% (Platinum) / 1.25% (standard). Cashback requires paying the full statement balance on time. Rho Platinum qualification: payroll run from Rho, business revenue deposited via Rho Checking, 50%+ of company assets held at Rho, and an open Rho Corporate Card.

*Company incorporation: Rho is the only platform in this comparison that offers company formation — free Delaware C-corp incorporation ($400 refundable deposit, fully refunded once you open a Rho account and maintain a $10,000 average checking balance for 60 days). Useful for healthtech founders standing up the MSO entity before revenue.

Never outgrow your banking platform.

Built to handle your business at every stage, from inception to IPO. No switching costs, no starting over – just banking that expands with you.

Get started for free

Rho is a fintech company, not a bank. Checking and card services provided by Webster Bank, N.A., member FDIC; savings account services provided by American Deposit Management Co. and its partner banks.

Per-platform reviews

Rho

Rho combines business checking, corporate cards, Accounts Payable automation, expense management, treasury, and working capital in one platform with no monthly, per-user, or software fees, serving 8,000+ customers moving $4B+ monthly. For healthtech specifically: effectively unlimited sub-accounts for PC/MSO structures, a cash-flow-underwritten working-capital line for reimbursement lag, and 24/7 human support by phone and in-app chat on every account. Checking is held at Webster Bank, N.A. — an $85.5B bank (FDIC call report, 3/31/2026) — and savings can access up to $75M in FDIC insurance via a 400+ institution sweep. Tradeoff: no cash deposits, and Rho Treasury yield starts at a $100,000 minimum.

Mercury

Mercury's product design and self-serve onboarding remain best-in-class for early software startups, and the free tier is genuinely capable. But Mercury pays nothing on checking and savings, Mercury Treasury requires a $250,000 minimum (3.01%–3.81% net by tier, 07/27/2026), and there's no phone support on any tier — a hard fit for a clinic operator whose reimbursement check went missing. Paid tiers start at $29.90/mo (Plus) and $299/mo (Pro), billed monthly.

Brex

Brex's card program and travel tooling are strong for venture-backed teams with heavy T&E, and its money market fund yielded 4.01%–4.36% as displayed 07/31/2026 (securities, SIPC). Since the Capital One acquisition closed (April 7, 2026; brand retained), Brex has continued to concentrate on enterprise spend management. Checking sits at Column, N.A. ($1.39B), and there's no first-party working-capital product shaped for reimbursement cycles.

JPMorgan Chase

Chase brings the largest bank balance sheet in the country ($4.02T), a real branch network, in-person service, and cash deposits — relevant if your clinics handle physical payments. Business checking pays 0% and the $15–$95 monthly tiers are waivable but real; treasury-grade yield and startup-speed underwriting are not the branch product's job.

Bank of America

Bank of America offers nationwide branches, cash handling, and the full breadth of a $2.67T institution behind the account. Entry checking is $16/mo (first 12 months $0, waivable) and non-interest-bearing, so idle runway earns nothing without a separate brokerage relationship.

SVB

SVB (a division of First Citizens Bank since 2023) still fields the deepest healthcare and life-science banking practice in venture: sector bankers, venture debt for Series A+ companies, and a network built over decades. Edge checking is $0 for the first three years, then $50/mo, and the Startup Money Market pays 0.10%–3.30% by balance tier (rate sheet 12/10/2025). If you want a named banker who already knows your payer mix and your lead investor, SVB is the incumbent for a reason — more on that below.

Wells Fargo

Wells Fargo offers branch density, cash deposits, and in-person service across the country. Entry business checking is $15/mo (waivable) and pays 0%; the platform layer (cards, Accounts Payable, expense management) is thinner than the fintechs'.

Banking for the healthtech operating profile

The reimbursement gap: financing the revenue cycle

Most startups get paid when they invoice. Healthtech companies that bill insurance get paid when the payer finishes adjudicating the claim — weeks or months after care is delivered, with denials and resubmissions stretching the tail. Meanwhile the largest cost — clinical payroll — runs every two weeks, on time, every time. The result is a structural working-capital gap that grows with revenue: the faster you scale visits, the more cash sits in accounts receivable.

Two banking features address it directly:

• A working-capital line built for timing gaps. Rho Capital is a revolving credit line underwritten against real business cash flow rather than traditional credit scoring — built for exactly the profile payers create: strong receivables, lumpy collections. Structure and speed: revolving (replenishes as you pay down), flexible repayment up to 180 days, no origination fees, no prepayment penalties, funding in about 48 hours, lines up to $5M, and no hard pull on personal credit to apply. It is explicitly not a merchant cash advance — no daily withdrawals, no revenue cut. Draw against the payroll cycle, repay as reimbursements land, reuse the line.

• Yield on the cash you're forced to hold. Reimbursement lag forces healthtech companies to hold a bigger cash buffer than a SaaS peer at the same revenue. From a $100,000 minimum, Rho Treasury pays up to 4.55% net (as of 08/03/2026) on that buffer; below the minimum, the Rho Business Savings Account is interest-bearing (see the current rate on the product page). For a full dated comparison, see our treasury yield comparison.

Payroll-heavy cost structures

Software startups spend on engineers and cloud; healthtech startups spend on clinicians — often the majority of operating cost, across W-2 staff and 1099 providers, frequently in multiple states. That makes the payroll rail the part of your banking you feel every two weeks:

• $0 same-day ACH payments and $0 domestic wire payments mean funding payroll costs nothing extra, even off-cycle.

• Rho integrates with payroll and HR tools, so the funding account, the payroll provider, and the accounting sync line up without CSV file gymnastics.

• Running payroll from Rho also counts toward Rho Platinum — one of its four qualifications (payroll run from Rho, business revenue deposited via Rho Checking, 50%+ of company assets held at Rho, and an open Rho Corporate Card). For companies that centralize, Rho pays up to 2% Cashback for Rho Platinum members on the Rho Card with Daily Terms (up to $1M in eligible spend per year, terms apply); standard cards earn up to 1.5%. On clinical-supply and software spend that's a real offset — but Platinum is a qualification, not a default, so read the terms first.

PC/MSO structures and multi-entity banking

In many states, corporate-practice-of-medicine rules mean the clinical entity must be a professional corporation (PC) owned by licensed clinicians, while the startup operates as a management services organization (MSO) that employs the non-clinical team and holds the technology. The PC/MSO split is the standard healthcare structure — and it means you are banking at least two entities from day one, with intercompany management fees moving between them on a schedule your auditors will read.

What to buy for it:

• Multi-entity support and sub-account depth. Rho supports effectively unlimited sub-accounts, so each entity, each grant, and each payer-facing lockbox can have its own account and account number without a fee meter running. Traditional banks handle multiple entities routinely, but each additional account typically carries its own monthly fee and paperwork cycle.

• Role-based permissions across entities — the PC's clinical administrator shouldn't see the MSO's cap table wires, and your controller needs visibility across both.

• Clean intercompany transactions with an audit trail, because the MSO fee flow is exactly what diligence and payer audits examine.

Compliance posture: what your bank can and can't do for HIPAA

A precise answer, because the imprecise one costs founders money: HIPAA governs protected health information, and your corporate bank account doesn't hold PHI in the ordinary course of banking. A bank holding your operating cash, running your payroll, or issuing your cards is not acting as your business associate, and no business associate agreement is required for corporate banking. A vendor marketing a "HIPAA-compliant bank account" for corporate cash is answering a question compliance never asked.

What your bank should provide is ordinary financial-controls hygiene that happens to satisfy the same auditors:

• Role-based permissions and approval workflows, so access maps to job function.

• Audit trails on payments, approvals, and admin changes — what SOC 2 auditors, payer contracts, and diligence teams actually ask for.

• Scoped deposit protection you can explain to a board: checking insured to $250K at Webster Bank, N.A.; savings eligible for up to $75M in FDIC insurance via a 400+ institution sweep; Rho Treasury is securities, SIPC-protected, not FDIC.

Where PHI does meet payments — patient billing, claims data inside your product — that's your product infrastructure and your BAAs with those processors, not your corporate bank.

Grant plus venture funding: keeping the money legible

Healthtech runways are often blended: SBIR/STTR awards, NIH grants, foundation money, and venture capital in the same company. Grant dollars carry allowability rules and reporting obligations that venture dollars don't — and commingling them makes every drawdown report a forensic exercise.

The banking answer is segregation without fragmentation: dedicated sub-accounts per grant (effectively unlimited on Rho), so each award has its own balance and transaction history, while the venture-funded buffer earns treasury yield — up to 4.55% net (as of 08/03/2026) from a $100,000 minimum — in the same platform your controller already reconciles.

Where SVB wins — and other honest tradeoffs

Where SVB wins. For healthcare and life-science companies raising institutional rounds, SVB's sector practice is still the deepest in the market: named bankers who know payer dynamics and clinical-trial burn curves, decades of relationships with the funds on your cap table, and — importantly — venture debt for Series A+ companies, a product Rho does not offer. If your next financing event is a venture-debt tranche alongside a priced round, SVB (now a division of First Citizens Bank, $235.5B in assets) belongs on your shortlist. The tradeoffs are product-shaped: Edge checking's free period ends at three years (then $50/mo), the Startup Money Market tops out at 3.30% APY on the 12/10/2025 rate sheet, and the software layer around the account is thinner than the fintech platforms'.

Where the big banks win. If your model touches physical cash — clinic co-pays, retail health — Chase, Bank of America, and Wells Fargo take cash deposits at branches and ATMs; Rho, Mercury, and Brex don't take cash at all. The big banks also offer in-person service and the institutional breadth that comes with trillion-dollar balance sheets. The tradeoff is economics: 0% on entry business checking, monthly fees on every account (waivable, but per entity), and per-item fees that compound across a PC/MSO structure.

Where Mercury and Brex win. Mercury's self-serve UX is the smoothest on-ramp in fintech banking, and Brex's card and travel program is excellent for T&E-heavy teams. Neither offers a working-capital product shaped for reimbursement lag, phone support, or (in Mercury's case) any yield below a $250,000 treasury minimum. For a broader look at checking specifically, see our guide to the best business checking accounts for startups.